]]]]]]]]]]]] BOWEL CANCER AND HEALTH RISKS [[[[[[[[[[[[ From Newsletter of (10/30/89) Thomas A. Dorman, M.D. (Freeman 93401DORM) Cancers begin small, in one place, and grow. Later they spread. That is what usually happens. One of the reasons skin cancers are not such a bad thing is because we can see them when they start and do something. Cancers on the inside of the body are not easy to see. Nonetheless many of the cancers which affect the internal organs begin on the lining of the food tube, which is called the gastero- intestinal tract. It is not a very polite fact, but a medical one, that cancers of the lower end are more common than the upper. The bowel can be inspected, the cancers identified and removed before it is too late. It is also known that cancers in the bowel can bleed, and not surprisingly, large cancers which have grown from little cancers and therefore have been there longer are more likely to bleed more often and in larger amounts. First a question for which you do not need to be a doctor: If you wanted to see if the sky is cloudy would you look out of the window, or would you put your hand out to feel for rain? Now a question for which you need a very impressive medical degree: If you wanted to see if there was a cancer in the bowel would you look in there, or would you test for bleeding? Dorman's Law No 2. When exhorted on scientific grounds to do the right thing, and when authority and statistics are quoted, look out for sleight of hand. Somebody is obscuring something. The profit and loss account might be a factor. Let us do a few rough calculations. The population over 45 years old in the U.S. is 73,461 million. The cause of death is 325,000 for heart disease, 191,700 for malignancies(1985 statistics). The expected incidence for colon cancers is 150,000, most of which occur in people over 60 years old. 40% of diagnosed bowel cancer cases are usually cured, which is the reaper's way of saying that death is postponed for another diagnosis. I am not being facetious when I put it this way, because Dorman's first law of medicine is that humans are mortal. Excuse me, but I just have to digress. I have been in S.L.O. for a dozen years, and about a year after my arrival I was looking after a gentleman aged 102. Though he had been in hospital and had been given a number of medical labels, like heart disease, he was hale and hearty. There was nothing wrong with him. He was cheerful and bright and at times grumpy and tired. He died. There was no special illness, no complaint from his heart or anything else. Yours truly wrote on the death certificate that he died of old age. A cardinal mistake. My education began. The coroner asked politely. I was strong. He died of old age. But soon "Sacramento" called. They only asked: Dr. what is your licence number? Does the BMQA know about you yet? Which university did you come from? In America, Dr., everyone has a diagnosis! It didn't take long for the patient to have died of heart disease (on the certificate). Lesson: Officially we are immortal. The law of certificates. They have to look impressive and stick to the rules. Facts and common sense don't count. But let's go back to bowel cancers. It is estimated that occult blood test screening in the stool (like putting your hand out to see if it is raining) costs $2.50 per screen per year and will pick up about 2.25 cancers per thousand of population screened, in a hitherto unscreened population. As most bowel cancers develop in individuals over 60, for the purpose of this little chat I will assume a retired population. The average money expended per person per year in America (for everything and that includes what you spend and what the governments spends on each human being) can perhaps be approximated by dividing the gross national product by the population P 3,947 billion for 239,283,000 = $14,565 per person (1985 numbers). It is hard to predict the increase in life span from a cure of bowel cancer as a general average, but a reasonable assumption is 7 years. 40% cure of 150,000 cases represents 60,000 cases a year to whom 7 years might be added. This is a best case scenario. Now assume non-productive life years; i.e., retired `years'. Next we should multiply the cost of these years, snatched from the reaper by their estimated total. 60,000 x $14,565 = $6,117 billion. This is the `cost' per annum. It is the national expenditure on non-productive American's life/years. Keep this little number in mind for a few more lines. The plot thickens. Now the average expense for a terminal cancer illness has been estimated at $21,200 for the last year of life, but we can't deduct this figure from the expense because everyone dies sometime. (The law of mortality). As an average, over the long haul, the death rate won't change, though the cause might. Everyone born to woman has to die! We will only find the same diagnoses in older people. That is a backwards way of saying people live longer. So let's go back to looking at the cost of prevention again, in my analogy looking for rain versus feeling for it. Sigmoidoscopy finds cancers earlier. First of all we should remember that it rains when it rains and bowel cancers bleed when they bleed. Most bowel cancers are without symptoms until it is too late. We should also remember that the unimproved cure rate from colon cancer reflects just those reported as colon cancer, not those reported as colon polyps, with malignancy in situ. In any case reporting of cancerous polyps is incomplete. Assume sigmoidoscopy to 60cm @ $150, every three years in the population at risk over 45. That is 3,82 million sigmoidoscopies = $573 million per year. At best this expense will detect about 110,000 cancers. (About 2 per thousand will develop cancer a year in the population over 45.) The screening cost P per cancer detected P is about $75,000. Given the 7 year addition to the life expectancy the life-expense, for those who got the extra years, will be $185,000. The national RloadS, not the good life - we are talking money and government controlled expense is $27 billion per annum. (Not all bowel cancers will be detected with sigmoidoscopy alone, assume an 80% detection rate.) An estimate for the decreased incidence of cancer after the first year of mass screening is in order in these calculations, because each cancer develops over about 4-5 years from a small polyp to a bad one. Against this we need to weigh the expense in screening the extra lives around. People who have had cancer are at increased risk for further cancer and screening every one to two years is recommended. Let us assume these numbers are about equal. We are left then with the following: For an 80% or better chance of prevention, i.e. early detection, you can spend $150 every four years for sigmoidoscopy. This will give you a 1/8 chance of increasing your life expectancy about 7 years and allowing you to spend an extra $75,000 for living expenses. If you rely on screening the cancers with bleeding when bleeding eventually occurs, i.e. later in the cancer's growth, you have a 40% chance of a cure. You are not likely to save money on your terminal illness as long as you are mortal. $27 billion per year spent on extra life and health costs represents 0.68% of the gross domestic product. Most cancers develop in the distal, or far down part, of the large bowel. A few develop higher up. To see them a longer instrument, a colonoscope, is needed. The test is more unpleasant and a tiny bit more risky. Barium enemas are also useful for detecting bowel cancer. In convenience and costs, the curve becomes exponential. In this practice your doctor has adopted the policy of recommending sigmoidoscopy every four years. Testing for occult blood in the stool is likely to pick up later and larger and more dangerous cancers - a second best. It is cheaper to the national exchequer. It would be cheapest, of course, if we all died on the day of retirement. In our civilization a doctor's responsibility is to his patients, their longevity and well-being. When the day comes that the doctor's responsibility is to the national exchequer - look out for the statistics. Here are the References:- The World in Figures; The Economist, 1986. Block, G.E. Colon cancer: diagnosis and prognosis in the elderly. Geriatrics; 1989 May. Enblad, P.; Adami, H.O.; Bergstrom, R.; Glimelius, B.; Krusemo, U.; Pahlman, L. Improved survival of patients with cancers of the colon and rectum? J Natl Cancer Inst; 1988 Jun 15. Eliakim, R.; Shabetai, O.; Rachmilewitz, D. Screening for fecal occult blood in Israel. Different approaches to recruitment. J Clin Gastroenterol; 1988 Apr. Long, S.H.; Gibbs, J.O.; Crozier, J.P.; Cooper, D.I. Jr; Newman, J.F. Jr; Larsen, A.M. Medical expenditures of terminal cancer patients during the last year of life. Inquiry.; 1984 Winter. Ayiomamitis, A. The epidemiology of malignant neoplasms of the large intestine in Canada: 1941-1985. J Clin Gastroenterol; 1989 Feb. Olsen, H.W.; Lawrence, W.A.; Snook, C.W.; Mutch, W.M. Risk factors and screening techniques in 500 patients with benign and malignant colon polyps. An urban community experience. Dis Colon Rectum; 1988 Mar. * * *
Return to the ground floor of this tower
Return to the Main Courtyard
Return to Fort Freedom's home page